GRDN Stock — Guardian Pharmacy Services, Inc.

Guardian Pharmacy Services, Inc. (GRDN)

Updated October 16, 2026.

GRDN is a Stock. Total return is 146.7% over the past 2.1 years, 110.3 points ahead of SPY at 36.4%.

Guardian Pharmacy Services operates a technology-enabled pharmacy service business serving long-term care facilities across the United States, including assisted living facilities, behavioral health facilities, and group homes. The company provides clinical services, drug dispensing and administration, and software tools such as Guardian Compass for business operations management and GuardianShield Programs for quality assurance. As an operating company with no established distribution history, it does not currently pay distributions and may appeal primarily to growth-oriented investors rather than income-focused ones.

GRDN performance versus SPY

Price and return data through 2026-10-16.

Total return is 146.7% over the past 2.1 years, 110.3 points ahead of SPY at 36.4%. Over the past year its total return — price change plus distributions reinvested — is 62.0%. Its deepest 1-year drawdown was 17.8%.

GRDN key facts

Asset type

Stock

Asset class

Equity

Inception date

09/26/2024

Distribution frequency

None

Last close

$39.47 (as of 2026-10-16)

Market cap

$2,499,252,241

Average volume

426033.0

Beta

0.023

Payout ratio

0.0%

P/E ratio

38.32

Forward P/E

30.2115

EPS

$1.03

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

GRDN risks and drawbacks

The deepest 1-year drawdown on record here is 17.8%.

Who may consider GRDN — and who may not

It is a weaker fit for investors who need monthly cash flow (GRDN does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on GRDN

• All tickers starting with G

Tagged: Healthcare.

Frequently asked questions